Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERTUGLIFLOZIN PIDOLATE for Glycosylated haemoglobin increased: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 11 adverse event reports in the FDA FAERS database where ERTUGLIFLOZIN PIDOLATE was used for Glycosylated haemoglobin increased.

Most Reported Side Effects for ERTUGLIFLOZIN PIDOLATE

Side Effect Reports % Deaths Hosp.
Fungal infection 58 8.5% 0 0
Product dose omission issue 57 8.4% 0 1
Nausea 55 8.1% 0 8
No adverse event 53 7.8% 0 0
Urinary tract infection 52 7.6% 0 13
Diabetic ketoacidosis 34 5.0% 0 30
Dizziness 33 4.9% 0 8
Vomiting 31 4.6% 0 7
Blood glucose increased 30 4.4% 0 3
Product dose omission 27 4.0% 0 0
Drug ineffective 21 3.1% 0 2
Inability to afford medication 21 3.1% 0 0
Rash 20 2.9% 0 0
Diabetes mellitus inadequate control 19 2.8% 0 7
Diarrhoea 19 2.8% 0 3

Other Indications for ERTUGLIFLOZIN PIDOLATE

Type 2 diabetes mellitus (198) Diabetes mellitus (192) Blood glucose abnormal (25) Product used for unknown indication (13) Blood glucose increased (10) Diabetes mellitus management (5)

Other Drugs Used for Glycosylated haemoglobin increased

TIRZEPATIDE (564) EXENATIDE (408) DULAGLUTIDE (307) SEMAGLUTIDE (229) METFORMIN (76) EMPAGLIFLOZIN (71) DAPAGLIFLOZIN PROPANEDIOL (65) ALBIGLUTIDE (57) CANAGLIFLOZIN (55) SITAGLIPTIN (41)

Related Pages

ERTUGLIFLOZIN PIDOLATE Full Profile All Glycosylated haemoglobin increased Drugs ERTUGLIFLOZIN PIDOLATE Demographics ERTUGLIFLOZIN PIDOLATE Timeline